Early Laxatives Linked to Better Survival in Critically Ill Pancreatitis Patients

Critically ill patients with acute pancreatitis who received a laxative within 48 hours of intensive care unit admission showed significantly better 28-day survival than those who did not, according to a retrospective cohort study drawing on the MIMIC-IV database. Among 1,061 adults admitted to the ICU with a primary diagnosis of acute pancreatitis, 705 received early laxatives and 356 did not. After propensity score matching produced 355 balanced pairs, early laxative exposure was independently associated with a decreased hazard of 28-day mortality, with a hazard ratio of 0.464 (95% confidence interval, 0.316–0.681; P < 0.001).

The study, published in BMC Gastroenterology, used all-cause mortality at 28 days as its primary outcome. Kaplan–Meier analysis showed significantly higher 28-day survival in the early laxative group, with a log-rank P value of 0.002. After 1:1 propensity score matching, all standardized mean differences fell below 0.1, indicating good balance between the matched groups on measured baseline characteristics.

The rationale for examining laxatives rests on the role of the gut in severe acute pancreatitis. The authors note that intestinal dysfunction, including impaired gastrointestinal motility, disruption of the gut barrier, and gut-derived inflammatory activation, contributes to systemic inflammation and organ dysfunction in the disease. Laxatives are commonly used in the ICU to counter gastrointestinal motility disorders, but the impact of starting them early on pancreatitis outcomes had remained unclear.

The retrospective design used the Medical Information Mart for Intensive Care IV database, enrolling adult patients admitted to the ICU with a primary diagnosis of acute pancreatitis. Early laxative exposure was defined as receipt of any laxative medication within 48 hours after ICU admission. Beyond survival, the researchers evaluated three secondary outcomes: occurrence of acute kidney injury, use of invasive mechanical ventilation, and development of sepsis.

The secondary analysis produced a cautionary signal. Early laxative exposure was associated with a significantly elevated risk of acute kidney injury, with an odds ratio of 2.11 (95% confidence interval, 1.42–3.13; P < 0.001). In contrast, the associations between early laxative use and the need for invasive mechanical ventilation or the occurrence of sepsis were not statistically significant.

The authors frame the survival association carefully. Among critically ill patients with acute pancreatitis, early laxative administration was associated with improved 28-day survival, and the results raise the possibility that early gastrointestinal modulation could serve as a modifiable factor influencing short-term outcomes. However, they emphasize that given the observational design and the potential for residual confounding, prospective studies are required to determine whether laxative therapy provides a causal clinical benefit.

That distinction matters for interpretation. In a retrospective database cohort, the decision to prescribe laxatives early may correlate with unmeasured factors such as clinician judgment about disease trajectory, feeding practices, or overall intensity of care, and propensity score matching can only balance the variables that were recorded. The observed mortality difference should therefore be read as an association in this population, not as proof that laxatives caused the improved survival.

The kidney injury finding adds a further layer of complexity for any future trial design. If early laxatives were ultimately confirmed to aid survival while simultaneously raising the risk of acute kidney injury, clinicians would need to weigh both effects, and the mechanism linking laxative exposure to renal outcomes in this cohort was not established by the study.

Acute pancreatitis carries a high risk of morbidity and mortality, a risk that is significantly amplified when the disease course requires intensive care.

For now, the study’s contribution is to identify a testable hypothesis rather than to change practice. The matched analysis suggests that the timing of gastrointestinal modulation in the first 48 hours of ICU admission may matter in acute pancreatitis, and the authors’ stated conclusion is that prospective studies are needed before any claim of causal benefit can be made.

Subject of Research: Early laxative administration and short-term mortality in critically ill acute pancreatitis patients

Article Title: Impact of early laxative administration on short-term mortality in critically ill acute pancreatitis patients: insights from the MIMIC-IV database

Article References: Cao, Z., Wang, J., Deng, R., Bi, C., & Li, J. (2026). Impact of early laxative administration on short-term mortality in critically ill acute pancreatitis patients: insights from the MIMIC-IV database. BMC Gastroenterology. https://doi.org/10.1186/s12876-026-05469-y

Image Credits: AI Generated

DOI: 10.1186/s12876-026-05469-y

Keywords: acute pancreatitis, laxatives, MIMIC-IV, ICU, mortality, propensity score matching, acute kidney injury, retrospective cohort study, gastrointestinal motility, critical care, Impact, early